NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Read carefully:

H.R. 1629, the Fairness in Orphan Drug Exclusivity Act, which amends existing legislation to require drugmakers who receive seven years of market exclusivity for a drug that treats a nonrare disease to provide regular updates to the FDA explaining why they can’t reasonably expect to recoup research and development costs from sales within 12 years of launch.